Drug Shortage Report for CLADRIBINE INJECTION
Report ID | 220112 |
Drug Identification Number | 02494574 |
Brand name | CLADRIBINE INJECTION |
Common or Proper name | CLADRIBINE INJECTION |
Company Name | GENERIC MEDICAL PARTNERS INC |
Market Status | MARKETED |
Active Ingredient(s) | CLADRIBINE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1mg/ml 10ml Vial |
ATC code | L01BB |
ATC description | ANTIMETABOLITES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-01-25 |
Actual start date | 2024-01-25 |
Estimated end date | 2024-02-26 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-02-21 |
Company comments | It was expected that GMP Cladribine 1mg/ml 10 ml vials would be available for sale from mid-February 2024. A short delay will occur before GMP Cladribine 1mg/ml 10 ml vials will be released. It is now expected that stock will be available for sale from February 26 2024. A communication will be issued on the actual day of release. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1500 DON MILLS ROAD, SUITE 711 TORONTO, ONTARIO CANADA M3B 3K4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-02-21 | French | Compare |
v1 | 2024-02-21 | English | Compare |
Showing 1 to 2 of 2